GLP-1 medications can help manage type 2 diabetes and obesity, but they may cause short-term mild-to-moderate side effects such as nausea, vomiting, diarrhoea, constipation, bloating, and decreased appetite, particularly at the beginning of treatment
A large preclinical toxicity program run across mice, rats, rabbits, and dogs found BPC-157 well tolerated with no serious treatment-related toxicity, no identifiable lethal dose, and no genotoxic or teratogenic signal, which is the strongest safety data point available by Xu 2020
Weight Loss Potential Tirzepatide: Early studies show it might lead to more weight loss
The findings, published online July 30 in the Proceedings of the National Academy of Sciences , build on extensive animal research
Long-term use of CJC-1295 and ipamorelin can also support lean muscle growth, collagen production, and enhanced overall vitality